Art therapy for patients with Progressive Supranuclear Palsy
Art Therapy in Progressive Supranuclear Palsy: Studying the Effect on Quality of Care
This study tests whether art therapy can help people with Progressive Supranuclear Palsy feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Sex | All |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Trial ID | NCT06588673 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of art therapy on individuals diagnosed with Progressive Supranuclear Palsy (PSP). The approach focuses on alleviating PSP symptoms, enhancing patients' quality of life, and reducing caregiver stress through various art-based activities. By promoting cognitive and motor skills, the study aims to address the emotional and psychological challenges faced by this patient population. The research seeks to fill a gap in understanding the potential benefits of art therapy specifically for PSP, a condition that has not been extensively studied in this context.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with Progressive Supranuclear Palsy who have the cognitive ability to provide informed consent.
Not a fit: Patients with primary neurological diagnoses other than Progressive Supranuclear Palsy or those whose cognitive impairment prevents them from providing informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life for patients with PSP and alleviate stress for their caregivers.
How similar studies have performed: While art therapy has shown positive outcomes in related neurodegenerative disorders like Parkinson's disease, its application in PSP remains largely untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of progressive supranuclear palsy * Have the cognitive ability to provide informed consent Exclusion Criteria: * Primary neurological diagnosis other than progressive supranuclear palsy * Cognition too impaired to provide informed consent
Where this trial is running
Nashville, Tennessee
- Vanderbilt University Medical Center — Nashville, Tennessee, United States (Recruiting)
Study contacts
- Study coordinator: Amy E Brown, MD
- Email: amy.brown@vumc.org
- Phone: 615-322-7343
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.